VEGFA and acute myeloid leukemia: Some growth factor pathways have been reported to show significant impacts on the development of AML, especially vascular endothelial growth factor (VEGF) could offer leukemia cells advantages on proliferation, survival, and chemotherapy resistance via both autocrine and paracrine manners (Dias et al., 2001; Papaemmanuil et al., 2016).